WESTERN BLOTTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Western blotting is a laboratory technique used to detect a specific protein in a blood or tissue sample. The method involves using gel electrophoresis to separate the sample's proteins. The separated proteins are transferred out of the gel to the surface of a membrane. The membrane is exposed to an antibody specific to the target protein. The binding of the antibody is detected using a radioactive or chemical tag. A western blot is sometimes used to diagnose disease. By using a western blot, researchers can identify specific proteins from a complex mixture of proteins extracted from cells. The technique uses three elements to accomplish this task: (1) separation by size, (2) transfer to a solid support, and (3) marking target protein using a proper primary and secondary antibody to visualize. Various steps in western blotting include tissue preparation, gel electrophoresis, transfer of proteins onto the membrane, blocking to prevent membrane and antibody interactions, incubation of membrane, and antibody-based detection of proteins.

Market Dynamics

Increasing adoption of organic growth strategies, such as increasing awareness about western blotting by key players in the market to expand their product portfolio, is expected to drive market growth over the forecast period. For instance, in January 2021, Bio-Rad Laboratories, Inc., a developer and manufacturer of specialized technological products for life science research and clinical diagnostics, announced the launch of the Bio-Rad Western Blotting Learning Center, an online library that provides comprehensive resources, information, and guidance to help researchers improve their experimental western blotting (or immunoblotting) approaches to obtain high-quality data.

Key features of the study:

• This report provides in-depth analysis of the global western blotting market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global western blotting market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study are Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., Leinco Technologies
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global western blotting market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global western blotting market

Detailed Segmentation:

• Global Western Blotting Market, By Products Type:
  • Electrophoresis Blotting Systems
    • Automated Dry Blotting Systems
    • Semi-Dry Blotting Systems
    • Traditional Wet Transfer Blotting Systems
  • Reagents & Kits
    • Chromogenic Reagents Kits
    • Chemiluminescent Reagents Kits
      • Horseradish Peroxidase (HRP) Substrate
      • Alkaline Phosphatase (AP) Substrate
    • Fluorescent Reagents
    • Antibodies
      • Primary Antibody
      • Secondary Antibody
    • Buffer Kits
  • Transfer Membranes
• Global Western Blotting Market, By Application:
  • Scientific Research
  • Medical Diagnostics
  • Agricultural Application
  • Food & Beverages
  • Other Applications
• Global Western Blotting Market, By End User:
  • Diagnostic Laboratories
  • Research Institutions
  • Pharmaceutical & Biotechnology Companies
• Global Western Blotting Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Thermo Fisher Scientific, Inc.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GE HealthCare
  • Hoffmann-La Roche Ltd
  • Lumigen, Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • LI-COR, Inc.
  • Bio-Techne
  • SBH Sciences
  • Advansta Inc.
  • Azure Biosystems Inc.
  • HiMedia Laboratories.
  • Elabscience Biotechnology Inc.
  • GenScript
  • Cell Signaling Technology, Inc.
  • ICL, Inc.
  • Takara Bio Inc.
  • Leinco Technologies

 “*” marked represents similar segmentation in other categories in the respective section.